Cart

No products in the cart.

100% Secure Checkout!

BLOG

One year later…dealing with SARS-CoV-2 variants

One year after the SARS-CoV-2 was declared a pandemic, over 110 million cases and 2.5 million deaths worldwide, unprecedented lockdowns, quarantines and economic devastation, several vaccine candidates have been approved by regulatory authorities. But what do the emergence of new SARS-CoV-2 mean for vaccination and the end of the global pandemic?

Continue Reading >>

How Chicken Polyclonal Antibodies Can Solve a Global Pandemic

Several studies have been performed demonstrating the applicability of IgY in diagnostic virology where it can be used as a biological input in immunoassays. In the first outbreak of SARS-CoV, an immunoswab assay was developed to detect the SARS-CoV nucleocapsid protein of the virus and compared the use of an IgG monoclonal antibody (mAb) with a chicken IgY antibody.

Continue Reading >>

One year later…dealing with SARS-CoV-2 variants

One year after the SARS-CoV-2 was declared a pandemic, over 110 million cases and 2.5 million deaths worldwide, unprecedented lockdowns, quarantines and economic devastation, several vaccine candidates have been approved by regulatory authorities. But what do the emergence of new SARS-CoV-2 mean for vaccination and the end of the global pandemic?

Continue Reading >>

How Chicken Polyclonal Antibodies Can Solve a Global Pandemic

Several studies have been performed demonstrating the applicability of IgY in diagnostic virology where it can be used as a biological input in immunoassays. In the first outbreak of SARS-CoV, an immunoswab assay was developed to detect the SARS-CoV nucleocapsid protein of the virus and compared the use of an IgG monoclonal antibody (mAb) with a chicken IgY antibody.

Continue Reading >>
Stay in touch!
Sign-up for our newsletter. We'll keep you updated!
Categories
Categories

Cart

No products in the cart.

100% Secure Checkout!

stay informed!

Subscribe to receive product updates & promotions.